SCHEMBL1048720

SCHEMBL1048720

CC(O)C(C)(N)P(=O)(O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 6/20 0.50
LMNA P02545 1/20 0.39
GRM4 Q14833 1/20 0.36
LAP3 P28838 3/20 0.35
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
CA9 Q16790 1/20 0.32
SMPD1 P17405 2/20 0.31
ANPEP P15144 3/20 0.31
ERAP1 Q9NZ08 1/20 0.31
PGK1 P00558 1/20 0.31
PGK2 P07205 1/20 0.31
GABRR1 P24046 1/20 0.30
GABBR2 O75899 1/20 0.30
GABBR1 Q9UBS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2510795 0.81 FDPS (0.52) FDPSLMNAGRM4LAP3SMPD1
SCHEMBL11196766 0.76 FDPS (0.46) FDPSLMNAGRM4LAP3SMPD1
SCHEMBL6777911 0.73 FDPS (0.44) FDPSLMNAGRM4LAP3SMPD1
SCHEMBL9792342 0.72 LMNA (0.43) FDPSLMNALAP3CA2PGK1
SCHEMBL8087725 0.70 FDPS (0.40) FDPSLMNALAP3ANPEPERAP1
SCHEMBL9632822 0.70 FDPS (0.46) FDPSLMNAGRM4LAP3SMPD1
SCHEMBL5355267 0.70
SCHEMBL366377 0.70
SCHEMBL8470467 0.69 FDPS (0.44) FDPSLMNAGRM4LAP3SMPD1
SCHEMBL143769 0.67 FDPS (1.00) FDPSLMNAGRM4LAP3CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070009981-A1 Nematode phosphoethanolamine N-methyltransferase-like sequences MONSANTO TECHNOLOGY LLC 2007-01-11 US claimed
EP-1390759-B1 ASSAY METHOD FOR PLATELET-ACTIVATING FACTOR DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-03-23 EP claimed
US-20040197293-A1 Anionic polyurethanes with elastic property L'OREAL S.A. (FR) 2004-10-07 US claimed
US-20040175776-A1 Assay method for platelet-activating factor ASUBIO PHARMA CO., LTD. (JP) 2004-09-09 US claimed
EP-1390759-A2 ASSAY METHOD FOR PLATELET-ACTIVATING FACTOR Daiichi Suntory Pharma Co., Ltd. (JP) 2004-02-25 EP claimed
WO-2002097435-A2 ASSAY METHOD FOR PLATELET-ACTIVATING FACTOR DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2002-12-05 WO claimed
WO-2001068870-A2 S-ADENOSYL-L-METHIONINE:PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE COMPOSITIONS AND METHODS FOR MODULATING LIPID BIOSYNTHESIS IN PLANTS UNIVERSITY OF FLORIDA (US) 2001-09-20 WO claimed
EP-4104186-A1 METHOD FOR AN AUTOMATIC, SEMANTIC-BASED, FUNCTIONAL TISSUE ANNOTATION OF HISTOLOGICAL AND CELLULAR FEATURES IN ORDER TO IDENTIFY MOLECULAR FEATURES IN TISSUE SAMPLES Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (DE) 2022-12-21 EP disclosed
US-20220142948-A1 COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2022-05-12 US disclosed
US-9673030-B2 Computer readable storage mediums, methods and systems for normalizing chemical profiles in biological or medical samples detected by mass spectrometry EMORY UNIVERSITY (US) 2017-06-06 US disclosed
US-8198060-B2 for drug screening; targets for anti-nematode vaccines, pesticides, and drugs DIVERGENCE, INC. (US) 2012-06-12 US disclosed
US-20110282587-A1 COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY EMORY UNIVERSITY (US) 2011-11-17 US disclosed
US-7867749-B2 Nematode phosphoethanolamine N-methyltransferase-like sequences DIVERGENCE, INC. (US) 2011-01-11 US disclosed
WO-2004103070-A2 NEMATICIDAL COMPOSITIONS AND METHODS DIVERGENCE, INC. (US) 2004-12-02 WO disclosed
US-20040197293-A1 Anionic polyurethanes with elastic property L'OREAL S.A. (FR) 2004-10-07 US disclosed
US-20040175776-A1 Assay method for platelet-activating factor ASUBIO PHARMA CO., LTD. (JP) 2004-09-09 US disclosed
US-20040091467-A1 Nematode phosphoethanolamine n-methyltransferase-like sequences MONSANTO TECHNOLOGY LLC 2004-05-13 US disclosed
EP-1390759-A2 ASSAY METHOD FOR PLATELET-ACTIVATING FACTOR Daiichi Suntory Pharma Co., Ltd. (JP) 2004-02-25 EP disclosed
WO-2004001011-A2 NEMATODE PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE-LIKE SEQUENCES DIVERGENCE, INC. (US) 2003-12-31 WO disclosed
WO-2002097435-A2 ASSAY METHOD FOR PLATELET-ACTIVATING FACTOR DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2002-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070009981-A1 Nematode phosphoethanolamine N-methyltransferase-like sequences PNMT, HNMT, GNMT FDPS 1607/4885LMNA 3432/4885GRM4 2171/4885
US-20040091467-A1 Nematode phosphoethanolamine n-methyltransferase-like sequences PNMT, HNMT, GNMT FDPS 1607/4885LMNA 3432/4885GRM4 2171/4885
US-20040197293-A1 Anionic polyurethanes with elastic property PUF60, PHOSPHO1, PLA2G2C FDPS 2917/4885LMNA 2132/4885GRM4 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.